These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31311769)

  • 1. Dormant origin signaling during unperturbed replication.
    Moiseeva TN; Bakkenist CJ
    DNA Repair (Amst); 2019 Sep; 81():102655. PubMed ID: 31311769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication.
    Moiseeva TN; Yin Y; Calderon MJ; Qian C; Schamus-Haynes S; Sugitani N; Osmanbeyoglu HU; Rothenberg E; Watkins SC; Bakkenist CJ
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13374-13383. PubMed ID: 31209037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1.
    Moiseeva T; Hood B; Schamus S; O'Connor MJ; Conrads TP; Bakkenist CJ
    Nat Commun; 2017 Nov; 8(1):1392. PubMed ID: 29123096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories.
    Ge XQ; Blow JJ
    J Cell Biol; 2010 Dec; 191(7):1285-97. PubMed ID: 21173116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An extending ATR-CHK1 circuitry: the replication stress response and beyond.
    Simoneau A; Zou L
    Curr Opin Genet Dev; 2021 Dec; 71():92-98. PubMed ID: 34329853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ATR-CHK1 signaling by ubiquitination of CLASPIN.
    Zhu X; Zheng XY; Gong P; Xu X
    Biochem Soc Trans; 2022 Oct; 50(5):1471-1480. PubMed ID: 36196914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase.
    Petermann E; Caldecott KW
    Cell Cycle; 2006 Oct; 5(19):2203-9. PubMed ID: 16969104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork.
    Saldanha J; Rageul J; Patel JA; Kim H
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATR prohibits replication catastrophe by preventing global exhaustion of RPA.
    Toledo LI; Altmeyer M; Rask MB; Lukas C; Larsen DH; Povlsen LK; Bekker-Jensen S; Mailand N; Bartek J; Lukas J
    Cell; 2013 Nov; 155(5):1088-103. PubMed ID: 24267891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claspin - checkpoint adaptor and DNA replication factor.
    Smits VAJ; Cabrera E; Freire R; Gillespie DA
    FEBS J; 2019 Feb; 286(3):441-455. PubMed ID: 29931808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling from Mus81-Eme2-Dependent DNA Damage Elicited by Chk1 Deficiency Modulates Replication Fork Speed and Origin Usage.
    Técher H; Koundrioukoff S; Carignon S; Wilhelm T; Millot GA; Lopez BS; Brison O; Debatisse M
    Cell Rep; 2016 Feb; 14(5):1114-1127. PubMed ID: 26804904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATR-Chk1 activation mitigates replication stress caused by mismatch repair-dependent processing of DNA damage.
    Gupta D; Lin B; Cowan A; Heinen CD
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1523-1528. PubMed ID: 29378956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.
    Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y
    J Virol; 2019 May; 93(9):. PubMed ID: 30787154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with ATR and CHK1 inhibitors does not substantially increase the mutational burden of human cells.
    Casimir L; Zimmer S; Racine-Brassard F; Goudreau F; Jacques PÉ; Maréchal A
    Mutat Res; 2023; 827():111834. PubMed ID: 37531716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fork and the kinase: a DNA replication tale from a CHK1 perspective.
    González Besteiro MA; Gottifredi V
    Mutat Res Rev Mutat Res; 2015; 763():168-80. PubMed ID: 25795119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATR and ATM regulate the timing of DNA replication origin firing.
    Shechter D; Costanzo V; Gautier J
    Nat Cell Biol; 2004 Jul; 6(7):648-55. PubMed ID: 15220931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-PKcs is required to maintain stability of Chk1 and Claspin for optimal replication stress response.
    Lin YF; Shih HY; Shang Z; Matsunaga S; Chen BP
    Nucleic Acids Res; 2014 Apr; 42(7):4463-73. PubMed ID: 24500207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CST in maintaining genome stability: Beyond telomeres.
    Lyu X; Sang PB; Chai W
    DNA Repair (Amst); 2021 Jun; 102():103104. PubMed ID: 33780718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging strategies for cancer therapy by ATR inhibitors.
    Yano K; Shiotani B
    Cancer Sci; 2023 Jul; 114(7):2709-2721. PubMed ID: 37189251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe.
    Patel JA; Zezelic C; Rageul J; Saldanha J; Khan A; Kim H
    Nucleic Acids Res; 2023 Jul; 51(12):6246-6263. PubMed ID: 37144518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.